Association of Bone Turnover Levels with MTHFR Gene Polymorphisms among Pregnant Women in Wuhan, China

Abstract

Pregnancy is a critical stimulator of bone mineral resorption. We used to find the MTHFR gene polymorphisms are related with blood lead levels among pregnant women. Pregnancy-stimulated bone turnover may be associated with MTHFR gene polymorphisms too. In this article, we aimed to determine the relationship between MTHFR gene polymorphisms and bone turnover rates among the pregnant women. The participants including pregnant and non-pregnant women were selected and recruited during their routine prenatal or physical examination from July to October in 2012. A total of 1000 participants, including 250 pregnant women in the first, second, and third trimesters and 250 non-pregnant women, were enrolled in the study. Finally, after excluding 27 participants unable to provide blood samples, 973 eligible participants (i.e., 234,249, and 248 pregnant women in the first, second, and third trimesters, respectively, and 242 non-pregnant women) were included in the research. The MTHFR gene 1298CC homozygote carriers were more susceptible to yield higher plasma homocysteine levels than the 1298AA/AC carriers, with standardized coefficients of 0.086 (P<0.05) and 0.104 (P<0.01) of all the participants and the pregnant women, respectively. The MTHFR gene 1793AA homozygote carriers more likely showed higher plasma osteocalcin levels (standardized β=0.091,P<0.01) than the 1793GG/GA carriers among all the subjects. Plasma homocysteine levels were positively correlated with blood lead levels among the participants and the pregnant women with standardized coefficients of 0.320 (P<0.01) and 0.179 (P<0.01), respectively. Plasma osteocalcin levels were positively associated with blood lead levels among pregnant and non-pregnant women with standardized coefficients of 0.084 (P<0.05) and 0.125 (P<0.01), respectively. In conclusion, homocysteine and osteocalcin contents in plasma are associated with the MTHFR gene A1298C polymorphism and blood lead levels among pregnant women. The MTHFR gene A1298C polymorphism-related homocysteine is a possible risk factor for increased blood lead levels among Chinese women.

Keywords

pregnant women / bone turnover levels / blood lead levels / MTHFR gene polymorphism

References

[1] Sanz-SalvadorL, Garcia-PerezMA, TarinJJ, et al.. Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture. Eur J Endocrinol, 2015, 172(2): R53-65

[2] AbramsSA. Normal acquisition and loss of bone mass. Horm Res, 200371-76

[3] EttingerAS, HuH, Hernandez-AvilaM. Dietary calcium supplementation to lower blood lead levels in pregnancy and lactation. J Nutr Biochem, 2007, 18(3): 172-178

[4] Tellez-RojoMM, Hernandez-AvilaM, Lamadrid-FigueroaH, et al.. Impact of bone lead and bone resorption on plasma and whole blood lead levels during pregnancy. Am J Epidemiol, 2004, 160(7): 668-678

[5] GundackerC, HengstschlagerM. The role of the placenta in fetal exposure to heavy metals. Wien Med Wochenschr, 2012, 162(9–10): 201-206

[6] BellingerDC. Teratogen update: lead and pregnancy. Birth Defects Res A Clin Mol Teratol, 2005, 73(6): 409-420

[7] WangH, LiuC. Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis. Osteoporos bit, 2012, 23(11): 2625-2634

[8] HuangQY, LiGH, KungAW. Multiple osteoporosis susceptibility genes on chromosome 1p36 in Chinese. Bone, 2009, 44(5): 984-988

[9] UranoT, InoueS. Genetics of osteoporosis. Biochem Biophys Res Commun, 2014, 452(2): 287-293

[10] SafarinejadMR, SafarinejadS, ShafieiN. Role of methylenetetrahydrofolate reductase gene polymorphisms (C677T, A1298C, and G1793A) in the development of early onset vasculogenic erectile dysfunction. Arch Med Res, 2010, 41(6): 410-422

[11] GreenTJ, McMahonJA, SkeaffCM, et al.. Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am J Clin Nutr, 2007, 85(2): 460-464

[12] AbrahamsenB, JorgensenHL, NielsenTL, et al.. MTHFR C.6770T polymorphism as an independent predictor of peak bone mass in Danish menresults from the Odense Androgen Study. Bone, 2006, 38(2): 215-219

[13] MiyaoM, MontaH, HosoiT, et al.. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int, 2000, 66(3): 190-194

[14] VilladsenMM, BungerMH, CarstensM, et al.. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Osteoporos Int, 2005, 16(4): 411-416

[15] JoergerM, HuoberJ. Prevention of Bone Metastases: 192 (Recent Results in Cancer Research), 2012

[16] MarshallWJ, LapsleyM, DayA, et al.. Clinical Biochemistry: Metabolic and Clinical Aspects (3rd edition), 2014

[17] ShenW, ZhangB, LiuS, et al.. Association of blood lead levels with methylenetetrahydrofolate reductase polymorphisms among Chinese pregnant women in Wuhan city. PLoS One, 2015, 10(2): ell7366

[18] BarbosaPR, StablerSP, MachadoAL, et al.. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur J Clin Nutr, 2008, 62(8): 1010-1021

[19] ChedrauiP, Salazar-PousadaD, VillaoA, et al.. Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in nulliparous women complicated with preeclampsia. Gynecol Endocrinol, 2014, 30(5): 392-396

[20] PoduriA, MukheijeeD, SudK, et al.. MTHFRA1298C polymorphism is associated with cardiovascular risk in end stage renal disease in North Indians. Mol Cell Biochem, 2008

[21] KluijtmansLA, YoungIS, BorehamCA, et al.. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood, 2003

[22] van de r PutNM, GabreelsF, StevensEM. eia/.Asecond common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neuraltube defects?. Am J Hum Genet, 1998, 62(5): 1044-1051

[23] HansonNQ, Aras, YangF, et al.. C677TandA1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem, 2001, 47(4): 661-666

[24] LiZ, RenA, ZhangL, et al.. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol, 2006, 76(4): 237-240

[25] de BreeA, VerschurenWM, Bjorke-MonsenAL, et al.. Effect of the methylenetetrahydrofolate reductase 677C~>T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr, 2003, 77(3): 687-693

[26] WinkelmayerWC, HuberA, WagnerOF, et al.. Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Kidney Int, 2005, 67(5): 1980-1985

[27] SafarinejadMR, ShafieiN, SafarinejadS. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and Gl 793A) gene and risk of prostate cancer: a case-control study. Prostate, 2010, 70(15): 1645-1657

[28] ChiaSE, AliSM, LeeBL, et al.. Association of blood lead and homocysteine levels among lead exposed subjects in Vietnam and Singapore. Occup Environ Med, 2007, 64(10): 688-693

[29] SchaferJH, GlassTA, BresslerJ, et al.. Blood lead is a predictor of homocysteine levels in a populationbased study of older adults. Environ Health Perspect, 2005, 113: 31-35

[30] YakubM, IqbalMP. Association of blood lead (Pb) and plasma homocysteine: a cross sectional survey in Karachi, Pakistan. PLoS One, 2010ell706

[31] KriegEJ, ButlerMA. Blood lead, serumhomocysteine, and neurobehavioral test performance in the third National Health and Nutrition Examination Survey. Neurotoxicology, 2009, 30(2): 281-289

[32] van Guidener, StehouwerCD. Homocysteine metabolism in renal disease. Clin Chem Lab Med, 2003, 41(11): 1412-1417

[33] MachidaM, SunSJ, OgumaE, et al.. High bone matrix turnover predicts blood levels of lead among perimenopausal women. Environ Res, 2009, 109(7): 880-886

[34] MonirAU, GundbergCM, YagermanSE, et al.. The effect of lead on bone mineral properties from female adult C57/BL6 mice. Bone, 2010, 47(5): 888-894

[35] MilgramS, CarriereM, ThiebaultC, et al.. Cytotoxic and phenotypic effects of uranium and lead on osteoblastic cells are highly dependent on metal speciatioll. Toxicology, 2008, 250(1): 62-69

[36] TojoY, KurabayashiT, HondaA, et al.. Bone structural and metabolic changes at the end of pregnancy and lactation in rats. Am J Obstet Gynecol, 1998180-185

[37] LeesCJ, JeromeCP. Effects of pregnancy and lactation on bone in cynomolgus macaques: histomorphometric analysis of iliac biopsies. Bone, 1998, 22(5): 545-549

[38] DobnigH, KainerF, StepanV, et al.. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab, 1995, 80(12): 3699-3707